For the first time in more than 25 years, the U.S. Food and Drug Administration has signed off on a new type of pain reliever ...

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...

The first shot taken at Medicaid, likely UnitedHealthcare coverage for Vertex's pain drug, and Optum’s wellness visit ad.

Journavx is the first new type of pain reliever approved by the FDA to hit the market in more than two decades. Emory ...

The FDA has approved the first new type of pain medication in more than two decades — and it’s not an opioid. The drug is Suzetrigine under the brand name Journavx. It is now FDA-approved to treat ...

The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

Experts said millions of people across the country are prescribed a medicine for moderate to severe acute pain each year, so ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...

Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in November, ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.